|
|
|
Saturday, February 26, 2011 — 7:00 p.m., CC 006 A-D
|
- Problems and Controversies in Thyroid Carcinomas of Follicular Cell Origin
|
|
Moderators:
|
Ronald Ghossein, Memorial Sloan-Kettering Cancer
Center, New York, NY and
Ricardo V. Lloyd, University of
Wisconsin Medicine and Public Health, Madison, WI
|
|
|
Disclosure:
|
In accordance with ACCME guidelines regarding disclosure, the USCAP policy requires that faculty members who have a significant financial or other relationship with a commercial company, entity, or service (which will be discussed in this Symposium) must disclose this to attendees. The Academy also requires that speakers disclose any products that are not labeled for the use under discussion. The speakers listed below have indicated they have nothing to disclose. |
Click the button above to add this event to your Itinerary Planner...
| 7:00 | Fine Needle Aspiration of the Thyroid
- William C. Faquin, Massachusetts General Hospital, Boston, MA |
| 7:45 | Follicular Patterned Tumors of the Thyroid
- Virginia A. LiVolsi, University of Pennsylvania, Philadelphia, PA |
| 8:30 | Poorly Differentiated Thyroid Carcinomas
- Giovanni Tallini, University of Bologna School of Medicine,
Bologna, Italy |
| 9:15 | Molecular Diagnostics in Thyroid Tumors
- Yuri Nikiforov, University of Pittsburgh School of Medicine,
Pittsburgh, PA |
|
The topics of the program were chosen based on a review of the programs from recent meetings, and consultations with members of the society including past officers. This symposium will address the most recent advances in cytopathology, histopathology and molecular pathology aimed at better diagnosing and therefore treating and investigating follicular cell derived thyroid malignancies. The classification of thyroid carcinomas of follicular cell origin is still subject to considerable controversies. These problems have an impact on the management of thyroid carcinomas patients and on the clinic-pathologic and molecular research performed to advance the field. The objective of the program is to arm surgical pathologists and cytologists with the tools needed to generate up to date and clinically relevant diagnosis. |
|
|
|
